426 related articles for article (PubMed ID: 11319919)
41. Functional reconstitution of oxidase activity in X-linked chronic granulomatous disease by retrovirus-mediated gene transfer.
Zentilin L; Tafuro S; Grassi G; Garcia R; Ventura A; Baralle F; Falaschi A; Giacca M
Exp Cell Res; 1996 Jun; 225(2):257-67. PubMed ID: 8660913
[TBL] [Abstract][Full Text] [Related]
42. Increased levels of spliced RNA account for augmented expression from the MFG retroviral vector in hematopoietic cells.
Krall WJ; Skelton DC; Yu XJ; Riviere I; Lehn P; Mulligan RC; Kohn DB
Gene Ther; 1996 Jan; 3(1):37-48. PubMed ID: 8929910
[TBL] [Abstract][Full Text] [Related]
43. Use of bicistronic retroviral vectors encoding the LacZ gene together with a gene of interest: a method to select producer cells and follow transduced target cells.
Staal FJ; Bakker AQ; Verkuijlen M; van Oort E; Spits H
Cancer Gene Ther; 1996; 3(5):345-51. PubMed ID: 8894254
[TBL] [Abstract][Full Text] [Related]
44. Gene therapy for hematopoietic and immune disorders.
Kohn DB
Bone Marrow Transplant; 1996 Dec; 18 Suppl 3():S55-8. PubMed ID: 8971410
[TBL] [Abstract][Full Text] [Related]
45. Missense mutation in exon 7 of the common gamma chain gene causes a moderate form of X-linked combined immunodeficiency.
Schmalstieg FC; Leonard WJ; Noguchi M; Berg M; Rudloff HE; Denney RM; Dave SK; Brooks EG; Goldman AS
J Clin Invest; 1995 Mar; 95(3):1169-73. PubMed ID: 7883965
[TBL] [Abstract][Full Text] [Related]
46. T cell reconstitution by haploidentical BMT does not restore the diversification of the Ig heavy chain gene in patients with X-linked SCID.
Minegishi Y; Ishii N; Tsuchida M; Okawa H; Sugamura K; Yata J
Bone Marrow Transplant; 1995 Dec; 16(6):801-6. PubMed ID: 8750273
[TBL] [Abstract][Full Text] [Related]
47. Nonrandom X chromosome inactivation in natural killer cells from obligate carriers of X-linked severe combined immunodeficiency.
Wengler GS; Allen RC; Parolini O; Smith H; Conley ME
J Immunol; 1993 Jan; 150(2):700-4. PubMed ID: 8093460
[TBL] [Abstract][Full Text] [Related]
48. The murine interleukin-2 receptor gamma chain gene: organization, chromosomal localization and expression in the adult thymus.
DiSanto JP; Certain S; Wilson A; MacDonald HR; Avner P; Fischer A; de Saint Basile G
Eur J Immunol; 1994 Dec; 24(12):3014-8. PubMed ID: 7805729
[TBL] [Abstract][Full Text] [Related]
49. Retrovirus-mediated transfer of the human alpha-L-iduronidase cDNA into human hematopoietic progenitor cells leads to correction in trans of Hurler fibroblasts.
Huang MM; Wong A; Yu X; Kakkis E; Kohn DB
Gene Ther; 1997 Nov; 4(11):1150-9. PubMed ID: 9425437
[TBL] [Abstract][Full Text] [Related]
50. Improved post-transcriptional processing of an MDR1 retrovirus elevates expression of multidrug resistance in primary human hematopoietic cells.
Knipper R; Kuehlcke K; Schiedlmeier B; Hildinger M; Lindemann C; Schilz AJ; Fauser AA; Fruehauf S; Zeller WJ; Ostertag W; Eckert HG; Baum C
Gene Ther; 2001 Feb; 8(3):239-46. PubMed ID: 11313796
[TBL] [Abstract][Full Text] [Related]
51. Restoration of lymphoid populations in a murine model of X-linked severe combined immunodeficiency by a gene-therapy approach.
Lo M; Bloom ML; Imada K; Berg M; Bollenbacher JM; Bloom ET; Kelsall BL; Leonard WJ
Blood; 1999 Nov; 94(9):3027-36. PubMed ID: 10556186
[TBL] [Abstract][Full Text] [Related]
52. Transmissibility of murine stem cell virus-based retroviral vectors carrying both interleukin-12 cDNAs and a third gene: implications for immune gene therapy.
Lieu FH; Hawley TS; Fong AZ; Hawley RG
Cancer Gene Ther; 1997; 4(3):167-75. PubMed ID: 9171935
[TBL] [Abstract][Full Text] [Related]
53. CAG repeat mutation in the mouse IL-2 gene enables concurrent assessment of T- and B-cell-specific gene expression by northern analysis.
Szebeni J; Sykes M
Exp Clin Immunogenet; 1996; 13(2):117-9. PubMed ID: 9063704
[TBL] [Abstract][Full Text] [Related]
54. Intrinsic defects of B cell function in X-linked severe combined immunodeficiency.
White H; Thrasher A; Veys P; Kinnon C; Gaspar HB
Eur J Immunol; 2000 Mar; 30(3):732-7. PubMed ID: 10741387
[TBL] [Abstract][Full Text] [Related]
55. Constitutive systemic expression of IL-1Ra or soluble TNF receptor by genetically modified hematopoietic cells suppresses LPS induction of IL-6 and IL-10.
Doughty LA; Patrene KD; Evans CH; Boggs SS; Robbins PD
Gene Ther; 1997 Mar; 4(3):252-7. PubMed ID: 9135739
[TBL] [Abstract][Full Text] [Related]
56. Retroviral vector design studies toward hematopoietic stem cell gene therapy for mucopolysaccharidosis type I.
Pan D; Aronovich E; McIvor RS; Whitley CB
Gene Ther; 2000 Nov; 7(21):1875-83. PubMed ID: 11110421
[TBL] [Abstract][Full Text] [Related]
57. In vivo competitive studies between normal and common gamma chain-defective bone marrow cells: implications for gene therapy.
Otsu M; Sugamura K; Candotti F
Hum Gene Ther; 2000 Sep; 11(14):2051-6. PubMed ID: 11020803
[TBL] [Abstract][Full Text] [Related]
58. Preclinical studies of a new generation retroviral vector for ovarian cancer BRCA1 gene therapy.
Tait DL; Obermiller PS; Holt JT
Gynecol Oncol; 2000 Dec; 79(3):471-6. PubMed ID: 11104622
[TBL] [Abstract][Full Text] [Related]
59. Novel bicistronic retroviral vector expressing gamma-glutamylcysteine synthetase and the multidrug resistance protein 1 (MRP1) protects cells from MRP1-effluxed drugs and alkylating agents.
Rappa G; Lorico A; Hildinger M; Fodstad Ø; Baum C
Hum Gene Ther; 2001 Sep; 12(14):1785-96. PubMed ID: 11560771
[TBL] [Abstract][Full Text] [Related]
60. Patterns of X chromosome inactivation in haematopoietic cells of female carriers of X linked severe combined immunodeficiency.
Hendriks RW; Kraakman ME; Schuurman RK
Immunodeficiency; 1993; 4(1-4):263-5. PubMed ID: 8167715
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
